BGC > Produktsuche >

Drug Category: TREATMENT OF INFLUENZA
Site: Virupaksha Organics Ltd

Description:
EIDD-2801 derived from a N(4)-hydroxycytidine, is an orally bioavailable broad spectrum antiviral compound that is effective against SARS-CoV2 infection.

• Molecular Weight:329.31
• Purity:95%

Molecular Formula:
C13H19N3O7
Canonical SMILES:
CC(C)C(=O)OCC1C(C(C(O1)N2C=CC(=NC2=O)NO)O)O
InChI:
InChI=1S/C13H19N3O7/c1-6(2)12(19)22-5-7-9(17)10(18)11(23-7)16-4-3-8(15-21)14-13(16)20/h3-4,6-7,9-11,17-18,21H,5H2,1-2H3,(H,14,15,20)/t7-,9-,10-,11-/m1/s1
InChIKey:
HTNPEHXGEKVIHG-QCNRFFRDSA-N
Solubility:
In vitro: 10 mM in DMSO
Appearance:
White to off-white (Solid)
Application:
Antiviral Agents
Storage: Powder: -20°C: 3 years 4°C: 2 years In solvent: -80°C: 6 months -20°C: 1 month
Synonyms:
Molnupiravir; EIDD 2801; EIDD2801; MK-4482; WHO 11853; N4-Hydroxycytidine, 5'-isopropyl ester; beta-D-N4 Hydroxycytidine-5'-isopropyl ester